Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis
Nutrition, Metabolism and Cardiovascular Diseases · 2024-06 · 34 (6) · 1339-1351
DOI: 10.1016/j.numecd.2024.04.007 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2024-06. Verfasst von Sen Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital, Chengdu Medical College, Chengdu 610500, Sichuan, China; Sichuan Clinical Research Center fo…. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Cardiovascular Diseases, Blood Glucose, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND AND AIM: The impact of the loss-of-function (LOF) genetic variant PCSK9 R46L on glucose homeostasis and cardiovascular disease (CVD) remains uncertain, despite its established correlation with diminished blood cholesterol levels. This meta-analysis aimed at exploring the effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and CVD. METHODS AND RESULTS: PubMed, Embase, and the Cochrane Library were searched for cohort and case-control studies published until October 1, 2023. The studies should report the association of the PCSK9 R46L genetic variant with one of the following: fasting plasma insulin, blood glucose levels, diabetes mellitus, and CVD risk. A dominant model of the PCSK9 R46L genetic variant was employed to statistical analysis. The meta-analyses were performed for continuous variables with standard mean difference (SMD), categorical variables with odds ratio (OR) using a random-effects model. A total of 17 articles with 20 studies engaging 1,186,861 population were identified and mobilized for these analyses. The overall results indicated that, compared with non-carriers of the PCSK9 R46L genetic variant, carriers of the PCSK9 R46L genetic variant did not increase or decrease the levels of fasting plasma insulin (3 studies with 7277 population; SMD, 0.08; 95% CI, -0.04 to 0.19; P = 0.270), and the levels of fasting plasma glucose (7 studies with 9331 population; SMD, 0.03; 95% CI, -0.08 to 0.13; P = 0.610). However, carriers of the PCSK9 R46L genetic variant indeed had 17% reduction in the risk of CVD (11 studies with 558,263 population; OR, 0.83; 95% CI, 0.71 to 0.98; P = 0.030), and 9% increase in the risk of diabetes mellitus (10 studies with 744,466 population; OR, 1.09; 95% CI, 1.04 to 1.14; P < 0.01). Meta-regression analyses indicated that the increased risk of diabetes mellitus and the reduced risk of CVD were positively correlated with reduction in LDL-C (P = 0.004 and 0.033, respectively). CONCLUSIONS: PCSK9 R46L genetic variant exhibited an elevated susceptibility to diabetes mellitus alongside a reduced vulnerability to CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital, Chengdu Medical College, Chengdu 610500, Sichuan, China; Sichuan Clinical Research Center for Geriatrics, The First Affiliated Hospital of Chengdu Medical College…
- Department of Ultrasound Medicine, Xindu District People's Hospital of Chengdu, Chengdu 610500, Sichuan, China. Electronic address: fang198@foxmail.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Wan, J., Wang, D., Yang, Y., Fang, J., Luo, T., Liang, D., Hu, J., Hou, J., & Wang, P. (2024). Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 34(6), 1339-1351. https://doi.org/10.1016/j.numecd.2024.04.007
Vancouver
Liu S, Wan J, Wang D, Yang Y, Fang J, Luo T, et al. Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2024;34(6):1339-1351. doi:10.1016/j.numecd.2024.04.007
BibTeX
@article{Liu2024,
author = {Liu, Sen and Wan, Jindong and Wang, Dan and Yang, Yi and Fang, Jie and Luo, Tao and Liang, Dengpan and Hu, Jun and Hou, Jixin and Wang, Peijian},
title = {Effect of the PCSK9 R46L genetic variant on plasma insulin and glucose levels, risk of diabetes mellitus and cardiovascular disease: A meta-analysis},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2024},
volume = {34},
number = {6},
pages = {1339--1351},
doi = {10.1016/j.numecd.2024.04.007}
}
EUVIMED